International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

间充质干细胞 细胞疗法 临床试验 计算生物学 免疫系统 间质细胞 再生医学 效力 医学 生物 免疫学 癌症研究 生物信息学 干细胞 体外 细胞生物学 生物化学
作者
Jacques Galipeau,Mauro Krampera,John Barrett,Francesco Dazzi,Robert Deans,Joost Dick de Bruijn,Massimo Dominici,Willem E. Fibbe,Adrian P. Gee,Jeffery M. Gimble,Peiman Hematti,Mickey Koh,Katarina LeBlanc,Iván Martín,Ian McNiece,Michael Mendicino,Steve Oh,Luis A. Ortiz,Donald G. Phinney,Valérie Planat‐Benard
出处
期刊:Cytotherapy [Elsevier BV]
卷期号:18 (2): 151-159 被引量:570
标识
DOI:10.1016/j.jcyt.2015.11.008
摘要

Mesenchymal stromal cells (MSCs) as a pharmaceutical for ailments characterized by pathogenic autoimmune, alloimmune and inflammatory processes now cover the spectrum of early- to late-phase clinical trials in both industry and academic sponsored studies. There is a broad consensus that despite different tissue sourcing and varied culture expansion protocols, human MSC-like cell products likely share fundamental mechanisms of action mediating their anti-inflammatory and tissue repair functionalities. Identification of functional markers of potency and reduction to practice of standardized, easily deployable methods of measurements of such would benefit the field. This would satisfy both mechanistic research as well as development of release potency assays to meet Regulatory Authority requirements for conduct of advanced clinical studies and their eventual registration. In response to this unmet need, the International Society for Cellular Therapy (ISCT) addressed the issue at an international workshop in May 2015 as part of the 21st ISCT annual meeting in Las Vegas. The scope of the workshop was focused on discussing potency assays germane to immunomodulation by MSC-like products in clinical indications targeting immune disorders. We here provide consensus perspective arising from this forum. We propose that focused analysis of selected MSC markers robustly deployed by in vitro licensing and metricized with a matrix of assays should be responsive to requirements from Regulatory Authorities. Workshop participants identified three preferred analytic methods that could inform a matrix assay approach: quantitative RNA analysis of selected gene products; flow cytometry analysis of functionally relevant surface markers and protein-based assay of secretome. We also advocate that potency assays acceptable to the Regulatory Authorities be rendered publicly accessible in an "open-access" manner, such as through publication or database collection.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
缺粥发布了新的文献求助10
刚刚
华仔的应助被吴呜呜采纳,获得10
1秒前
所所的应助被1111采纳,获得10
1秒前
Micheallee完成签到,获得积分10
1秒前
Hello的应助被老汉憨憨采纳,获得10
2秒前
科研通AI6.4的应助被dde采纳,获得30
2秒前
3秒前
个性天晴完成签到 ,获得积分10
4秒前
4秒前
鲤鱼鑫磊发布了新的文献求助10
4秒前
丘比特的应助被zyy采纳,获得30
4秒前
111发布了新的文献求助10
4秒前
5秒前
科研通AI65的应助被西北采纳,获得10
5秒前
5秒前
5秒前
搞怪冷之完成签到 ,获得积分10
5秒前
5秒前
科研通AI2S的应助被小佳采纳,获得10
6秒前
天天快乐的应助被尹兴亮采纳,获得10
7秒前
EvanWang发布了新的文献求助10
8秒前
雪白的雪完成签到,获得积分10
8秒前
Cuchaoji发布了新的文献求助10
8秒前
李健的应助被顺利的海白采纳,获得10
8秒前
脑洞疼的应助被繁星采纳,获得10
10秒前
廖翰彬发布了新的文献求助10
10秒前
姜姗完成签到 ,获得积分10
11秒前
冷艳的火龙果完成签到,获得积分10
11秒前
12秒前
SciGPT的应助被典雅土豆采纳,获得10
12秒前
心灵美的石头完成签到,获得积分10
12秒前
Celeste完成签到 ,获得积分10
12秒前
初景的应助被高大的凝芙采纳,获得20
12秒前
15秒前
15秒前
懵懂的海露完成签到,获得积分10
15秒前
15秒前
15秒前
Lucas的应助被Cuchaoji采纳,获得10
16秒前
zyy发布了新的文献求助30
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820